CMF regimen clinical trials
How each study uses CMF regimen is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the CMF regimen studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- CMF regimen
- 10
Studies by the year they started
10 studies that test it; most in 1996 (3)
| Year | Studies |
|---|---|
| 1992 | 1 |
| 1993 | 1 |
| 1996 | 3 |
| 1998 | 2 |
| 2001 | 1 |
| 2002 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 10
Scottish Cancer Therapy Network (2) · European Organisation for Research and Treatment of Cancer - EORTC (1) · NCIC Clinical Trials Group (1) · University Hospital Birmingham (1) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1) · SWOG Cancer Research Network (1) · Memorial Sloan Kettering Cancer Center (1) · Leiden University Medical Center (1)
Often tested with
Tested in the same studies.
Epirubicin (3) · Cyclophosphamide (2) · Fluorouracil (2) · Trastuzumab (1) · Tamoxifen (1) · Doxorubicin (1) · Paclitaxel (1) · Methotrexate (1)
Studies
Open first, then newest update. How each study uses CMF regimen is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 10
- A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast CancerRecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT07768436Written as CMF Regimen
- Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast CancerCompletedPhase 2European Organisation for Research and Treatment of Cancer - EORTCNCT00036868Written as CMF regimen
- Tamoxifen in Treating Women With High-Risk Breast CancerCompletedPhase 3NCIC Clinical Trials GroupNCT00002542Written as CMF regimen
- Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast CancerCompletedPhase 3University Hospital BirminghamNCT00003577Written as CMF regimen
- Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast CancerStatus unknownPhase 2Leiden University Medical CenterNCT00002498Written as CMF regimen
- Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast CancerCompletedPhase 3Scottish Cancer Therapy NetworkNCT00003012Written as CMF regimen
- Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast CancerStatus unknownPhase 3Scottish Cancer Therapy NetworkNCT00003680Written as CMF regimen
- Chemotherapy Plus Surgery in Treating Women With Breast CancerCompletedPhase 3Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoNCT00003013Written as CMF regimen
- S9716: Combination Chemotherapy in Treating Patients With Merkel Cell CancerCompletedPhase 2SWOG Cancer Research NetworkNCT00003549Written as CMF regimen
- Combination Chemotherapy in Treating Women With Resected Breast CancerStatus unknownPhase 2Institute of Cancer Research, United KingdomNCT00033683Written as CMF regimen